Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Be a candidate for a new arteriovenous graft~* Be either currently on dialysis or ready to begin dialysis as soon as the access device (AV graft with Hemoaccess Valve System) is ready for use.~* Be prepared to receive dialysis at dialysis centers in proximity of study centers~* Have an outflow vein of greater than or equal to 3mm in diameter to which the graft can be successfully anastomosed.~* Be able to communicate with study personnel.~* Be considered by the physician to be readily available for subsequent visits.~* Be willing to comply with all aspects of the treatment and evaluation as directed over the duration of the study.~* Allow representatives of the Sponsor, the designated Clinical Research Organization, the Institutional Review Board and the FDA to review his/her relevant medical records that pertain to this study.~Exclusion Criteria:~* An identification of a central venous stenosis on the ipsilateral side is documented or otherwise identified~* An identification of an arterial venous stenosis on the ipsilateral side is documented or otherwise identified~* A hypercoagulable state is documented or otherwise identified and/or previous AV access failures have occurred without an identifiable cause.~* Has a life expectancy of less than one year.~* An immunodeficiency syndrome~* An organ transplant is expected within 6 months of enrollment~* 3 or more previous new AV graft or fistula placements have occurred.~* Body habitus (e.g., extremely small or obese arms( precludes HVS device implantation or access.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hemoaccess Valve System (Type: EXPERIMENTAL): Valve system for use with AV graft

Based on this trial design, predict the completion outcome and termination type (if applicable).